Repro Med Systems Inc (KRMD) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Repro Med Systems Inc

NASDAQ | KRMD

2.36

USD

-0.19 (-7.45%)

AT CLOSE (AS OF Apr 3, 2025)

$117M

MARKET CAP

P/E Ratio

-0.13

EPS

$5.1

52 Week High

$2.1

52 Week Low

LIFE SCIENCES

Sector

KRMD Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

KRMD Technicals

Tags:

KRMD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$21M
Total Revenue	$34M
Cost Of Revenue	$12M
Costof Goods And Services Sold	$12M
Operating Income	-$5.6M
Selling General And Administrative	$22M
Research And Development	$5.3M
Operating Expenses	$27M
Investment Income Net	-
Net Interest Income	$445K
Interest Income	$445K
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$888K
Income Before Tax	-$6.1M
Income Tax Expense	-$2.9K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.1M
Comprehensive Income Net Of Tax	-
Ebit	-$6.4M
Ebitda	-$5.6M
Net Income	-$6.1M

Revenue & Profitability

Earnings Performance

KRMD Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$27M
Total Current Assets	$19M
Cash And Cash Equivalents At Carrying Value	$9.6M
Cash And Short Term Investments	$9.6M
Inventory	$2.8M
Current Net Receivables	$5.7M
Total Non Current Assets	$8.1M
Property Plant Equipment	$4.3M
Accumulated Depreciation Amortization Ppe	$3.5M
Intangible Assets	$730K
Intangible Assets Excluding Goodwill	$730K
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$750K
Other Non Current Assets	$99K
Total Liabilities	$10M
Total Current Liabilities	$7.2M
Current Accounts Payable	$1.6M
Deferred Revenue	-
Current Debt	$387K
Short Term Debt	$516K
Total Non Current Liabilities	$3.2M
Capital Lease Obligations	$203K
Long Term Debt	$271K
Current Long Term Debt	$271K
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$271K
Other Current Liabilities	$29K
Other Non Current Liabilities	-
Total Shareholder Equity	$17M
Treasury Stock	$3.9M
Retained Earnings	-$29M
Common Stock	$494K
Common Stock Shares Outstanding	$46M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$320K
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$888K
Capital Expenditures	$1.3M
Change In Receivables	-
Change In Inventory	$678K
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$249K
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$6.1M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$21M
Total Revenue	$34M
Cost Of Revenue	$12M
Costof Goods And Services Sold	$12M
Operating Income	-$5.6M
Selling General And Administrative	$22M
Research And Development	$5.3M
Operating Expenses	$27M
Investment Income Net	-
Net Interest Income	$445K
Interest Income	$445K
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$888K
Income Before Tax	-$6.1M
Income Tax Expense	-$2.9K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.1M
Comprehensive Income Net Of Tax	-
Ebit	-$6.4M
Ebitda	-$5.6M
Net Income	-$6.1M

KRMD Profile

Repro Med Systems Inc Profile

Sector: LIFE SCIENCES

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company is headquartered in Chester, New York.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	334,149,797
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.19	1,684.81%	$19.91M	117,875
PTIX	$0.42	84.14%	$4.04M	177,332,811
MRM	$0.65	74.84%	$2.91M	51,693,935
OSRH	$2.47	68.03%	$40.06M	89,471,971

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

KRMD $2.36 (-7.45%) Quote details